Zobrazeno 1 - 10
of 207
pro vyhledávání: '"R.P. Symonds"'
Autor:
C. Talbot, A. Webb, E. Harper, D. Azria, A. Choudhury, D. de Ruysscher, A. Dunning, R. Elliott, S. Kerns, M. Lambrecht, T. Rancati, B. Rosenstein, P. Seibold, E. Sperk, A. Vega, L. Veldeman, J. Chang-Claude, C. West, T. Rattay, R.P. Symonds
Publikováno v:
Radiotherapy and Oncology. 170:S321-S323
Autor:
H. Jandu, C.D. Veal, D. Azria, J. Chang-Claude, A.M. Dunning, D. de Ruysscher, L. Fachal, S. Gutiérrez-Enríquez, T. Rancati, B.S. Rosenstein, M.C. de Santis, P. Seibold, E. Sperk, R.P. Symonds, A. Vega, L. Veldeman, A. Webb, C. West, C.J. Talbot, T. Rattay
Publikováno v:
European Journal of Cancer. 175:S38
Autor:
C. Rosas, T. Rattay, D. Azria, R.M. Elliott, S. Gutiérrez-Enríquez, T. Rancati, B.S. Rosenstein, D. De Ruysscher, E. Sperk, H. Stobart, R.P. Symonds, C.J. Talbot, M.C. De Santis, A. Vega, L. Veldeman, A. Webb, C.M. West, J. Chang-Claude, P. Seibold
Publikováno v:
Radiotherapy and Oncology. 170:S723-S724
Autor:
E. Rammant, E. Deman, L. Poppe, R. Bultijnck, P. Dirix, G. De Meerleer, K. Haustermans, A. Van Hecke, D. Azria, J. Chang-Claude, A. Choudhury, D. De Ruysscher, M. Lambrecht, B.S. Rosenstein, P. Seibold, E. Sperk, R.P. Symonds, R. Valdagni, A. Vega, A. Webb, C. West, L. Veldeman, V. Fonteyne, S. Van Hoecke
Publikováno v:
European Urology. 81:S1687-S1688
Publikováno v:
Clinical Oncology (Royal College of Radiologists (Great Britain)
Aims In the field of radiogenomics, several potential predictive genetic markers have been identified that are associated with individual susceptibility to radiation toxicity. Predictive models of radiation toxicity incorporating radiogenomics and ot
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A. Webb, Alison M. Dunning, Rebecca Elliott, E. Harper, Barry S. Rosenstein, Ananya Choudhury, Tiziana Rancati, Jenny Chang-Claude, D. Azria, Liv Veldeman, Sarah L. Kerns, Petra Seibold, R.P. Symonds, Tim Rattay, M. Lambrecht, Elena Sperk, Catharine M L West, Ana Vega, Christopher J. Talbot, Dirk De Ruysscher
Publikováno v:
Radiotherapy and Oncology. 161:S1635
Autor:
J. Chang-Claude, Sara Gutiérrez Enríquez, Jenny Chang-Claude, Hubert Thierens, Ana Vega, David Azria, Liv Veldeman, Karen S. Johnson, Riccardo Valdagni, Rebecca Elliott, C.J. Talbot, Alison M. Dunning, Tom Burr, Dirk De Ruysscher, R.P. Symonds, Frederik Wenz, A. Webb, Tim Rattay, Samuel Lavers, R. Paul Symonds, P. Seibold, Anthony J. Brookes, Martin Yuille, Philippe Lambin, Susan E Davidson, Barry S. Rosenstein, C. West, Tiziana Rancati, C. Kyriacou, A.-M. Critchley, Catharine M L West, Petra Seibold, Christopher J. Talbot
Publikováno v:
Johnson, K, Chang-claude, J, Critchley, A, Kyriacou, C, Lavers, S, Rattay, T, Seibold, P, Webb, A, West, C, Symonds, R P, Talbot, C J, Azria, D, Brookes, A, Chang-claude, J, De Ruysscher, D, Dunning, A, Gutiérrez Enríquez, S, Lambin, P, Rancati, T, Rosenstein, B, Seibold, P, Symonds, R P, Thierens, H, Valdagni, R, Vega, A, Veldeman, L, Wenz, F & West, C 2019, ' Genetic Variants Predict Optimal Timing of Radiotherapy to Reduce Side-effects in Breast Cancer Patients ', Clinical Oncology, vol. 31, no. 1, pp. 9-16 . https://doi.org/10.1016/j.clon.2018.10.001
Aims Radiotherapy is an important treatment for many types of cancer, but a minority of patients suffer long-term side-effects of treatment. Multiple lines of evidence suggest a role for circadian rhythm in the development of radiotherapy late side-e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0796d0db8c6d3ec16489066efed382e
https://linkinghub.elsevier.com/retrieve/pii/S093665551830462X
https://linkinghub.elsevier.com/retrieve/pii/S093665551830462X
Autor:
D.N.Y. Peel, Caroline C Henson, R.P. Symonds, Susan E Davidson, Ric Swindell, H.J.N. Andreyev
Publikováno v:
Clinical Oncology. 23:552-557
Introduction 17,000 patients receive treatment with radical pelvic radiotherapy annually in the UK. Up to 50% of patients will develop bowel symptoms which affect quality of life. Services for this patient group are underdeveloped. Barriers to good c